Verified Nov 2026
Other
·

Frankfurt, Hesse
·
Since 2020
Merz Therapeutics is a specialty pharmaceutical company headquartered in Frankfurt, Germany, founded in 2020, with 1,000–5,000 employees and estimated revenue of $250–500 million. Part of the Merz Group, which traces its heritage to 1908, the company develops treatments for neurological movement disorders, neurodegenerative diseases, and related conditions. Its flagship product XEOMIN® addresses dystonia and spasticity, while recent efforts include Phase 2 trials for peripheral neuropathic pain and expanded approvals for cervical dystonia and blepharospasm in Japan.
Merz Therapeutics at a glance
Revenue
$250-500M
Est. band
Employees
1,000-5,000
Founded
2020
Headquarters
Frankfurt, Hesse
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
Merz Therapeutics is a specialty pharmaceutical company headquartered in Frankfurt, Germany, founded in 2020, with 1,000–5,000 employees and estimated revenue of $250–500 million. Part of the Merz Group, which traces its heritage to 1908, the company develops treatments for neurological movement disorders, neurodegenerative diseases, and related conditions. Its flagship product XEOMIN® addresses dystonia and spasticity, while recent efforts include Phase 2 trials for peripheral neuropathic pain and expanded approvals for cervical dystonia and blepharospasm in Japan.
At a glance
Attribute | Detail |
|---|---|
Founded | 2020 |
Headquarters | Frankfurt, Hesse |
Employees | 1,000-5,000 |
Revenue | $250-500M (estimated) |
What Merz Therapeutics makes
Merz Therapeutics manufactures and commercializes neurotoxin-based therapies, biopharmaceuticals for movement disorders, and treatments for neurodegenerative diseases including Alzheimer's and Parkinson's.
Latest developments
2026-10-26 — Merz Therapeutics Presents New Phase 2 PaiNT Data in Peripheral Neuropathic Pain at IASP 2026 - Merz Therapeutics : Merz Therapeutics (merztherapeutics.com)
2026-10-15 — Exp. CONTR 2025 0000510163-2 · 2ª PRO 3º CBAM MERZ THERAPEUTICS IBERIA SL Acuerdo marco para… | El Vínculo (el-vinculo.com)
2026-06-19 — Teijin Receives Approval for Additional Indications of XEOMIN® for Cervical Dystonia and Blepharospasm in Japan - Merz Therapeutics : Merz Therapeutics (merztherapeutics.com)
2026-06-11 — Merz Therapeutics strengthens partnership with Grünenthal in Brazil - Merz Therapeutics : Merz Therapeutics (merztherapeutics.com)
2026-05-26 — Merz Therapeutics and Kvvit Enter Exclusive Agreement for INBRIJA® (levodopa inhalation powder) in mainland China, Hong Kong and Macao - Merz Therapeutics : Merz Therapeutics (merztherapeutics.com)
2026-01-30 — Merz Therapeutics Appoints Dan Staner as President, Region Europe - Merz Therapeutics : Merz Therapeutics (merztherapeutics.com)
Facilities
Merz Therapeutics is headquartered in Frankfurt, Hesse. Public sources also reference these locations:
Poland — merztherapeutics.com
Frankfurt, Germany — merztherapeutics.com
Company details
As a privately held subsidiary of the Merz Group, the company operates facilities in Poland and Frankfurt and serves multiple therapeutic areas including dermatology, hair loss, and scar management. Merz Therapeutics was founded in 2020, has an estimated 1,000-5,000 employees, and is headquartered in Frankfurt, Hesse.
Frequently asked questions
What does Merz Therapeutics do?
Merz Therapeutics is a specialty pharmaceutical company headquartered in Frankfurt, Germany, founded in 2020, with 1,000–5,000 employees and estimated revenue of $250–500 million. Part of the Merz Group, which traces its heritage to 1908, the company develops treatments for neurological movement disorders, neurodegenerative diseases, and related conditions. Its flagship product XEOMIN® addresses dystonia and spasticity, while recent efforts include Phase 2 trials for peripheral neuropathic pain and expanded approvals for cervical dystonia and blepharospasm in Japan.
Where is Merz Therapeutics headquartered?
Merz Therapeutics is headquartered in Frankfurt, Hesse.
When was Merz Therapeutics founded?
Merz Therapeutics was founded in 2020.
How big is Merz Therapeutics?
Merz Therapeutics has an estimated 1,000-5,000 employees, with revenue in the $250-500M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
